AbbVie Deutschland GmbH & Co. KG

AbbVie was founded in 2013 as a global biopharmaceutical company aiming to address serious health issues. It investigates both small and large molecule approaches. Its focus areas include immunology, kidney disease, liver disease, neuroscience, oncology, and women's health. AbbVie Deutschland is headquartered in Wiesbaden, Germany. (Further information can be found on http://www.abbvie.com)